Sign up to save your podcasts
Or
Share GeoVax Labs to Present Clinical Data on COVID-19 Vaccine Candidate and Oncology Therapies at Industry Events
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
GeoVax Labs to Present Clinical Data on COVID-19 Vaccine Candidate and Oncology Therapies at Industry Events
GeoVax Labs, Inc. will be presenting clinical data at two upcoming industry events in April. The presentations will cover Phase 2b study results comparing GeoVax's GEO-CM04S1 vaccine candidate to an approved COVID-19 vaccine, as well as Gedeptin therapy for solid tumors. GeoVax is a biotechnology company focused on developing vaccines for infectious diseases and therapies for solid tumor cancers.
View all episodes
GeoVax Labs, Inc. will be presenting clinical data at two upcoming industry events in April. The presentations will cover Phase 2b study results comparing GeoVax's GEO-CM04S1 vaccine candidate to an approved COVID-19 vaccine, as well as Gedeptin therapy for solid tumors. GeoVax is a biotechnology company focused on developing vaccines for infectious diseases and therapies for solid tumor cancers.